CDH2 and breast cancer: In several carcinomas, inappropriate N-cadherins expression has been shown to contribute to a migratory phenotype [98, 99] and Katafiasz et al. have shown that in breast cancer cells the N-cadherin promotes motility independently from the expression of E-cadherin [100].